| 1 |
35081740 | Polymorphisms in the MSH2 gene predict poor survival of North Indian lung cancer patients undergoing chemotherapy. | 2022 Jan 27 |
1 |
| 2 |
32742474 | Genetic Variants in DNA Mismatch Repair Pathway predict prognosis of Lung Cancer patients with receiving Platinum-Based Chemotherapy. | 2020 |
1 |
| 3 |
30414698 | A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer. | 2019 Feb |
2 |
| 4 |
31273068 | Genetic polymorphisms in hMSH2 and hMLH1 genes are associated with prognosis in epithelial ovarian cancer patients. | 2019 Sep |
2 |
| 5 |
31666131 | Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer. | 2019 Oct 30 |
4 |
| 6 |
23810210 | ERCC1, MLH1, MSH2, MSH6, and βIII-tubulin: resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma. | 2013 Sep |
1 |
| 7 |
20458443 | Polymorphisms in hMSH2 and hMLH1 and response to platinum-based chemotherapy in advanced non-small-cell lung cancer patients. | 2010 May 15 |
2 |
| 8 |
19175039 | Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients. | 2008 Dec |
2 |
| 9 |
11496300 | Expression of DNA mismatch repair proteins hMSH2 and hMLH1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy. | 2001 Sep-Oct |
1 |
| 10 |
10778972 | Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. | 2000 Apr |
1 |
| 11 |
8807890 | The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. | 1996 Jul |
1 |